While adoption of personal health records and electronic patient portals increased from 2012 to 2015, researchers at Weill Cornell Medical found that the adoption rates for Hispanics and low-income individuals have lagged behind non-Hispanics and higher-income individuals.
While adoption of personal health records and electronic patient portals increased from 2012 to 2015, researchers at Weill Cornell Medical found that the adoption rates for Hispanics and low-income individuals have lagged behind non-Hispanics and higher-income individuals.
The Federal Electronic Health Record Incentive Program has been incentivizing healthcare providers and hospitals to adoption electronic health records and make electronic data available to patients. A randomized telephone survey of New Yorkers found that the proportion of New Yorkers using personal health records rose from 11% in 2012 to 27% in 2015. While black individuals were less likely to use personal health records and patient portals in 2012 compared with whites, the proportion of black individuals using these technologies rose sharply over the course of the survey.
However, the increased rate of Hispanics and low-income respondents (household income less than $50,000) using these technologies did not keep up.
Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis
October 24th 2024The authors evaluated whether adolescents receiving care at accountable care organizations (ACOs) vs non-ACOs were more likely to initiate and complete the human papillomavirus (HPV) vaccination series.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Rozanolixizumab Effective in Patients with MuSK MG, Analysis Shows
October 23rd 2024A new subgroup analysis of patients with muscle-specific tyrosine kinase (MuSK) autoantibody-positive (Ab+) myasthenia gravis (MG) shows rozanolixizumab (Rystiggo) contributes to meaningful symptom improvement.
Read More